Leviathan aspires to become a leading multi-jurisdictional cannabis enterprise, combining exceptional genetics and product formulations with ground breaking branding and marketing expertise, coupled with a proprietary global distribution  platform. The Leviathan portfolio currently comprises Jekyll+Hyde Brand Builders Inc., a marketing services agency specializing in the cannabis sector, and Woodstock Biomed Inc., a late stage applicant under the ACMPR, which is in the process of retrofitting a substantial greenhouse production facility in Pelham, Ontario. Leviathan has also announced its intention to acquire Pulse Rx Inc., a boutique-style pharmacy currently providing core pharmacy services to institutional clients including nursing and retirement homes. Pulse Rx will form an integral component in Leviathan's future retail distribution model for cannabis products.